- Home
- GDV vs ACAD Comparison
GDV vs ACAD Comparison
Compare GDV & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDV
- ACAD
- Stock Information
- Founded
- GDV 2003
- ACAD 1993
- Country
- GDV United States
- ACAD United States
- Employees
- GDV N/A
- ACAD N/A
- Industry
- GDV Investment Managers
- ACAD Biotechnology: Pharmaceutical Preparations
- Sector
- GDV Finance
- ACAD Health Care
- Exchange
- GDV Nasdaq
- ACAD Nasdaq
- Market Cap
- GDV 2.2B
- ACAD 2.6B
- IPO Year
- GDV N/A
- ACAD 2004
- Fundamental
- Price
- GDV $24.50
- ACAD $16.77
- Analyst Decision
- GDV
- ACAD Buy
- Analyst Count
- GDV 0
- ACAD 19
- Target Price
- GDV N/A
- ACAD $26.44
- AVG Volume (30 Days)
- GDV 186.0K
- ACAD 1.3M
- Earning Date
- GDV 01-01-0001
- ACAD 11-06-2024
- Dividend Yield
- GDV 5.81%
- ACAD N/A
- EPS Growth
- GDV N/A
- ACAD N/A
- EPS
- GDV N/A
- ACAD 0.78
- Revenue
- GDV N/A
- ACAD $929,236,000.00
- Revenue This Year
- GDV N/A
- ACAD $35.78
- Revenue Next Year
- GDV N/A
- ACAD $8.58
- P/E Ratio
- GDV N/A
- ACAD $21.92
- Revenue Growth
- GDV N/A
- ACAD 47.06
- 52 Week Low
- GDV $18.04
- ACAD $14.15
- 52 Week High
- GDV $23.00
- ACAD $32.59
- Technical
- Relative Strength Index (RSI)
- GDV 49.22
- ACAD 58.08
- Support Level
- GDV $23.96
- ACAD $14.41
- Resistance Level
- GDV $25.33
- ACAD $18.71
- Average True Range (ATR)
- GDV 0.24
- ACAD 0.67
- MACD
- GDV 0.01
- ACAD 0.22
- Stochastic Oscillator
- GDV 39.05
- ACAD 54.88
About GDV Gabelli Dividend & Income Trust of Beneficial Interest
Gabelli Dividend & Income Trust operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of total return on its assets with an emphasis on dividends and income. To achieve its objective, the fund may invest its assets in dividend-paying securities or other income-producing securities. The fund invests in various sectors, in which Financial Services, Food & Beverage, Health Care, Consumer Products, Electronics, and Computer Software & Services and others.
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.